Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Cash from Investing Activities (2022 - 2025)

Praxis Precision Medicines has reported Cash from Investing Activities over the past 4 years, most recently at -$328.4 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 2907.79% year-over-year to -$328.4 million; the TTM value through Dec 2025 reached -$311.1 million, down 25.21%, while the annual FY2025 figure was -$311.1 million, 25.21% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$328.4 million at Praxis Precision Medicines, down from $50.4 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $50.4 million in Q3 2025 and troughed at -$328.4 million in Q4 2025.
  • A 4-year average of -$28.3 million and a median of $5.0 million in 2023 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: surged 497.66% in 2023 and later plummeted 21736.0% in 2024.
  • Year by year, Cash from Investing Activities stood at $22.6 million in 2022, then tumbled by 100.22% to -$50000.0 in 2023, then plummeted by 21736.0% to -$10.9 million in 2024, then crashed by 2907.79% to -$328.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for PRAX at -$328.4 million in Q4 2025, $50.4 million in Q3 2025, and $17.9 million in Q2 2025.